Caracterização de peptídeos ligadores e indutores de IgE derivados da isoforma de ATP difosfohidrolase 1 de Schistosoma mansoni (SmATPDase 1)

Abstract

Schistosomiasis is a neglected disease caused by blood flukes (trematode worms) of the genus Schistosoma. This disease affects mostly communities without proper access to safe drinking water and adequate sanitation. Praziquantel is the only drug available for this infection and vaccines are currently unavailable at the market. The NTPDases are a family of proteins that catalyze the hydrolysis of nucleoside di and tri phosphates and are widely distributed in the organisms. In Schistosoma mansoni, two isoforms of NTPDases (SmATPDase1 and SmATPDase2) were described and might play important role in the parasite physiology. The SmATPase1 controls extracellular concentration of nucleoside di and tri phosphates, regulating blood clotting and immune system cells activation. In addition, this isoform might be one of the major IgE (a protective immunoglobulin) inducing antigen in the course of schistosomiasis infection. Thus, the inhibition of ATP-diphosphohydrolase by drugs or antibodies is an interesting strategy to target schistosomiasis. Intense Th2 response and high levels of IgE and cytokines IL-4, IL-5 and IL-13 are characteristic of helminth infections and allergies. It is suggested that this similarity is not only by chance, but it is due the fact that the allergic response started as a form of counter parasites - hypothesis supported by cross reactivity between proteins from parasites and allergens. In this work, we identified potential IgE epitopes in the linear structure of SmATPDase1 by in silico analysis. Three peptides were synthesized by solid phase and used in ELISA and immunization assays. The ELISA assays showed the capacity of these peptides to bind IgE and IgG4 antibodies in human serum and IgE and IgG1 in infected animals. However, no significant difference was found in the production of IgE and IgG1 after animal immunization with these molecules. Nevertheless, these immune sera were capable of identifying the SmATPDase1 in western blot assays and the identity of the enzyme was confirmed by mass spectrometry. These findings support the hypothesis that these peptides correspond to IgE epitopes. Furthermore, some results also suggest that these peptides are capable of binding natural antibodies that target self-proteins and are homologues to the investigated peptides. Thus, these peptides might be explored as tools for the study of NTPDases, through the production of antibodies against these epitopes, or as immunotherapeutics for treatment of allergies, auto-immune diseases and schistosomiasis.